# OnCo record relapsed-refractory (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/relapsed-refractory/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "relapsed-refractory" ;
  schema:name "Relapsed / refractory (R/R)"@en ;
  schema:alternateName "R/R"@en, "relapsed/refractory"@en, "relapsed or refractory"@en, "relapsed and refractory"@en, "refractory"@en, "relapsed"@en, "primary refractory"@en, "chemorefractory"@en, "chemo-refractory"@en, "treatment-refractory"@en, "heavily pretreated"@en, "pretreated"@en, "previously treated"@en, "triple-class refractory"@en, "penta-refractory"@en, "BCG-refractory"@en, "double-refractory"@en ;
  schema:description "Relapsed means the cancer came back after responding; refractory means it never responded or grew during treatment. 'R/R' is the label on most trials of new blood cancer drugs."@en ;
  schema:url <https://onco.cc/terms/relapsed-refractory/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Relapse> ;
  schema:citation <https://en.wikipedia.org/wiki/Relapse> ;
  onco:related <https://onco.cc/terms/first-line/>, <https://onco.cc/terms/salvage-therapy/>, <https://onco.cc/terms/platinum-sensitivity/>, <https://onco.cc/terms/accelerated-approval/>, <https://onco.cc/terms/resistance/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> .